logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Lawrence E Stramm

USPTO Granted Patents = 14

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 195(Granted Patents)


Company Filing History:

goldMedal14 out of 4,447 
 
Eli Lilly and Company
 patents

Years Active: 1996-2009

Loading Chart...
14 patents (USPTO):Explore Patents
1. RE40876 - Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof (2009-08-17),
2. 7223728 - Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat metabolic instability associated with non-insulin dependent diabetes (2007-05-29),
3. 6660716 - Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof (2003-12-09),
4. 6486179 - Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy (2002-11-26),
5. 6288053 - Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy (2001-09-11),
6. 6232299 - Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy (2001-05-15),
7. 6107327 - Therapeutic treatment for HIV infection (2000-08-22),
8. 6093740 - Therapeutic treatment for skin disorders (2000-07-25),
9. 6093709 - Therapeutic treatment for sexual dysfunctions (2000-07-25),
10. 5962446 - Therapetutic treatment for human T cell lymphotrophic virus type 1 (1999-10-05),
11. 5939387 - Method of treating insulin resistance (1999-08-17),
12. 5723456 - Therapeutic treatment for cardiovascular diseases (1998-03-03),
13. 5624953 - Pharmaceutical compounds (1997-04-29),
14. 5514706 - Pharmaceutical compounds (1996-05-07),

Title: The Innovative Mind of Lawrence E. Stramm: Transforming Diabetes Treatment

Introduction

Lawrence E. Stramm is a prominent inventor based in Indianapolis, IN, recognized for his significant contributions to the medical field, particularly in diabetes treatment. With an impressive portfolio of 14 patents, Stramm’s work has focused on innovative methods to improve the management of non-insulin dependent diabetes mellitus, which has profound implications for the healthcare community.

Latest Patents

Stramm's latest patents include groundbreaking methods for the treatment of non-insulin dependent diabetes, specifically utilizing thiazolidinediones (TZD) alongside glucagon-like peptide-1 (GLP-1) agonists. His first patent details a method for co-administering TZD and GLP-1 to enhance glycemic control while minimizing common side effects such as heart hypertrophy and elevated plasma glucose levels. This synergistic approach aims to regulate glucose homeostasis in Type II diabetic patients effectively. The second patent highlights the same innovative combination, emphasizing its role in addressing metabolic instability associated with non-insulin dependent diabetes.

Career Highlights

Stramm has dedicated his career to advancing diabetes treatment and has established himself as a key contributor at Eli Lilly and Company, a leader in pharmaceutical innovation. His work has not only expanded therapeutic options for diabetes management but has also paved the way for new research on combining existing medications to bolster their effectiveness and safety profiles.

Collaborations

In his endeavors, Stramm has collaborated with esteemed colleagues such as Michael R. Jirousek and Douglas Kirk Ways. These partnerships have fostered a dynamic environment for innovation, enabling a cross-disciplinary approach to tackling complex medical challenges related to diabetes and its associated complications.

Conclusion

Lawrence E. Stramm's innovative spirit and commitment to enhancing diabetes treatment exemplify the crucial role of inventors in the medical field. His work continues to influence patient care and offers hope for improved therapeutic strategies for those living with non-insulin dependent diabetes mellitus. Through his ongoing contributions, Stramm stands as an inspiration for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…